Skip to content

Effect of ropivacaine combined with dexmedetomidine on scalp nerve block for analgesia after general anesthesia and craniotomy

Effect of ropivacaine combined with dexmedetomidine on scalp nerve block for analgesia after general anesthesia and craniotomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021429
Enrollment
Unknown
Registered
2019-02-21
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frontotemporal space occupying lesion

Interventions

Sponsors

West China Hospital, Sichuan, University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 65 years old, body mass index 18~30kg/m2; preoperative ASA I or II level; consent to sign informed consent, with follow-up

Exclusion criteria

Exclusion criteria: Visual analog scales cannot be understood and used; patients with preoperative pain include trigeminal neuralgia; preoperative heart rate <60 beats/min or systolic blood pressure <100 mmHg; severe mental illness and cognitive dysfunction, unstable crown Heart disease, heart failure, arrhythmia, severe liver and kidney disease; other peripheral nerve block contraindications, such as local skin infections, coagulopathy, local anesthetics or right beauty allergy.

Design outcomes

Primary

MeasureTime frame
Total analgesic drug consumption within 24 hours after surgery;The first time after surgery, the use of analgesic drugs;

Secondary

MeasureTime frame
Intraoperative blood pressure and heart rate;Postoperative VAS score;Adverse reactions;

Countries

China

Contacts

Public ContactLI YU

West China Hospital, Sichuan University

biaojieli@tom.com+86 18980601545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026